Isifo sofuba esiswini (IBD) sinomthelela omkhulu kubantu ngokubodwa, okubangela ukugula nokukhubazeka okuholela ezinkingeni eziningi ezibandakanya ukungasebenzi, ukukhathazeka ngokwezezimali, izinkinga zomndeni, nokungabi nokuxhumana komphakathi. Kunzima ukubeka izandla zethu kulo lonke uhlobo lwe-IBD engathinta impilo yethu, izimo zethu zezezimali kanye nesimo sethu senhlalakahle.
Kodwa-ke, kukhona idatha ebalulekile esingayibheka ukuze sithole isithombe se-IBD esithinta ngayo njengomphakathi. Iyini impembelelo i-IBD inayo phakathi nonyaka uma sibheka izinombolo?
Ngonyaka ojwayelekile:
- Abantu abangaba ngu-1.6 million e-United States bahlala ne-IBD
- Amacala amasha angu-70 000 we-IBD atholakala e-United States
- Cishe amaphesenti angu-5 azo zonke iziguli ze-IBD zingaphansi kweminyaka engu-20
- Phakathi kwamaphesenti ayisishiyagalombili kuya kwangu-16 kubo bonke abagulayo be-IBD banabantu abaneminyaka engama-60 ubudala nangaphezulu
- Kubantu abane-ulcerative colitis:
- Amaphesenti angu-48 abhekana nokukhululwa
- Amaphesenti angu-30 abhekene nemisebenzi yesifo esincane
- Amaphesenti angu-20 abhekene nemisebenzi yesifo esilinganiselwe
- Amaphesenti angu-1 kuya ku-2 amaphesenti abhekene nokusebenza kanzima kwezifo
- Abantu abanesifo sikaCrohn:
- I-Akhawunti cishe mayelana nezigidi ezingu-1.1 ukuvakashela odokotela, imitholampilo, kanye neminyango ephuthumayo
- Thola mayelana nemigomo eyizigidi ezingu-1.8 ebhalelwe ukwelashwa
- I-Akhawunti yezingu-187,000 zokubeletha
- I-Akhawunti phakathi kwezingu-$ 8,265 nezigidi ezingu-18,963 ngesiguli ngasinye emibhalweni yomshuwalense
- Abantu abane-ulcerative colitis:
- I-Akhawunti ngokuvakashelwa okungaba ngu-716,000 odokotela, imitholampilo, neminyango ephuthumayo
- Thola mayelana nemigomo engu-2.1 million ebhalelwe ukwelashwa
- I-Akhawunti yezingu-107,000 zezibhedlela
- I-Akhawunti ephakathi kuka-$ 5,066 kanye no-$ 15,020 ngesiguli ngasinye esimangalo zomshuwalense
- I- Crohn's neColitis Foundation of America (i-CCFA) ilinganisela izindleko zonyaka ze-IBD eziphakathi kuka-$ 11 no-$ 28 billion
- Kulinganiselwa ukuthi amaphesenti angama-32 e-IBD ababhekene nezimpawu awaqashiwe
- Ngemiphumela yokungasebenzi, i-CCFA ilinganisela izindleko ze-IBD zibe phakathi kuka-$ 14.6 no-31.6 billion
Imithombo:
Ucwaningo lwe-CDC / NCHS lukazwelonke lokukhishwa kwesibhedlela: United States, 2010. Amasevisi Okulawulwa Nokuvimbela Izifo.
> Crohn's And Colitis Foundation of America. " Amaqiniso Ngokuphathelene Nezifo Zezifo Ezivuthayo ." [PDF] Nov 2014. 30 Aug 2014.
I-Gibson TB, Ng E, i-Ozminkowski RJ, et al. "Umthwalo wezindleko zikaCrohn kanye nesifo sokulonda kwesifo sofuba." I-Occup Environ Med . 2008; 50: 1261-1272. 30 Aug 2014.
Kappelman MD, Moore KR, Allen JK, Cook SF. "Amathrendi yakamuva ekusakazeni kwesifo sikaCrohn kanye nesifo sokulonda kwesilonda kubantu base-US abanomshwalense." I-Dig Dis Sci . 2013; 58: 519-525. 30 Aug 2014.
I-Kappelman MD, uRifas-Shiman SL, Porter CQ, et al. "Izindleko zokunakekelwa kwezempilo eziqondile zesifo sikaCrohn kanye ne-ulcerative colitis ezinganeni nasebantwini base-US." I-Gastroenterology . 2008; 135 (6): 1907-1913. 30 Aug 2014.
Langholz E, Munkholm P, Davidsen M, Binder V. "Inkambo ye-ulcerative colitis: ukuhlaziywa kwezinguquko emisebenzini yesifo eminyakeni eminingi." I-Gastro .
1994; 107: 3-11. 30 Aug 2014.
Loftus EV, Jr., Shivashankar R, Tremaine WJ, i-Harmsen WS, i-Zinsmeiseter AR. "Ukuvuselelwa Kwesifo Sezifo Ne-Ulcerative Colitis ku-Olmsted County, Minnesota (1970-2011)." Umhlangano Wezesayensi Yonyaka We-ACG 2014. Okthoba 2014. 30 Aug 2014.
Longobardi T, Jacobs P, Bernstein CN. "Ukulahlekelwa umsebenzi okuhlobene nesifo sofuba esifubeni e-United States: Imiphumela evela ku-National Health Interview Survey." Am J Gastro. 2003: 98,1064-1072. 30 Aug 2014.
> Ruhl CE, Sayer B, Byrd-Holt DD, Brown DM. Ku: Everhart JE, umhleli. "Umthwalo wezifo zokugaya ukudla eMelika." UMnyango WezeMpilo waseMelika kanye Nezinsizakalo Zabantu, Inkonzo Yempilo Yomphakathi, Izikhungo Zikazwelonke Zempilo, Isikhungo Sikazwelonke Sesifo Sikashukela kanye ne-Digestive and Kidney Diseases. Washington, DC: i-US Government Printing Office, 2008; I-NIH Publication No. 09-6443; 137-147. 30 Aug 2014.